Introduction
============

Rapid release of water-soluble signaling molecules through fusion of vesicles with the plasma membrane underlies most cell to cell communication in higher animals, including synaptic transmission ([@bib78]). The decisive property of the protein machinery driving fast exocytosis is the ability to arrest the process at an intermediate, release-ready or "cocked" state while blocking premature fusion. Upon Ca^2+^ influx, membrane fusion of release-ready vesicles proceeds to completion within a fraction of a millisecond. Much current research aims at identifying the molecular configuration of the intermediate state.

The neuronal SNARE complex ([@bib74]) is formed between a vesicular protein, synaptobrevin-2 (syb-2)/VAMP-2 ([@bib5]; [@bib22]) and an acceptor complex consisting of two plasma membrane proteins, syntaxin-1 ([@bib6]) and SNAP-25 ([@bib62]; for reviews see [@bib43]; [@bib51]; [@bib66]; [@bib79]). The resulting extended parallel bundle has the transmembrane anchors of both syb-2 and syntaxin-1 localized at the C-terminal end ([@bib39]; [@bib80]), which prompted the idea that sequential SNARE complex assembly in the N- to C-terminal direction would lead to membrane fusion ([@bib38]).

Several studies indicate that the t-SNARE syntaxin-1 ([@bib18]; [@bib36]; [@bib29]) and the partner S/M protein Munc18-1 ([@bib86]; [@bib91]; [@bib34]) are both involved in docking vesicles to the plasma membrane. Very recently it was found that the Ca^2+^ sensor synaptotagmin-1 (syt-1) induces docking of dense-core vesicles, probably by binding to a syntaxin--SNAP-25 dimer on the plasma membrane ([@bib19]). Other studies indicate that syb-2 is not involved in dense-core vesicle docking ([@bib9]; [@bib8]; [@bib29]), even though the situation is not entirely clear, owing to the use of different docking definitions in this field and possible mechanistic differences between synaptic and dense-core vesicle docking ([@bib82]). Overall, a picture is emerging in which vesicles associate with t-SNAREs, whereas synaptobrevin joins later. This raises the question at which stage the process is arrested before Ca^2+^ influx: at the level of the syntaxin--SNAP-25 dimer upstream of synaptobrevin nucleation or at a later step, in which the N-terminal part of synaptobrevin has already joined the complex? This question cannot be answered based on available data, as has recently been pointed out ([@bib77]). Mutagenesis of SNAP-25 in chromaffin cells revealed that C-terminal mutations interfered with fast Ca^2+^-dependent triggering of vesicle fusion, whereas mutations in the middle of the complex affected vesicle priming, the upstream process leading to the release-ready state ([@bib76]). However, the middle mutations might have affected processes upstream of synaptobrevin binding ([@bib19]). In vitro studies have shown that SNAREs can fuse vesicle populations, but generally this happens in a nonregulated fashion ([@bib89]; [@bib71]), and even though recent data suggest that fusion can be arrested by synaptotagmin after initial trans-SNARE pairing ([@bib13]), it is unclear whether this system can be generalized to the in vivo situation ([@bib77]). Another protein thought to be involved in generating the intermediate, clamped state is complexin. Because both synaptotagmin and complexin interact with the ternary SNARE complexes ([@bib12]; [@bib81]; [@bib17]), this could be taken as evidence that the intermediate state involves synaptobrevin already bound to syntaxin--SNAP-25. However, interactions of these proteins with syntaxin ([@bib6]; [@bib48]; [@bib95]), SNAP-25 ([@bib69]; [@bib99]), or the syntaxin--SNAP-25 complex ([@bib64]; [@bib7]; [@bib33]; [@bib92]) have also been identified.

In this study, we directly addressed the timing of synaptobrevin association to the fusion machinery. By correlating biochemical equilibrium binding data with physiological measurements of exocytosis, we conclude that most of the synaptobrevin SNARE bundle forms during the process that leads to the formation of the release-ready state of the vesicle. Only the most C-terminal SNARE interaction layers were involved in fusion triggering and fusion pore formation, indicating that a relatively small conformational change might suffice to drive the fusion of release-ready vesicles.

Results
=======

Mutagenesis of syb-2
--------------------

To characterize the timing of SNARE complex assembly in the process of neurotransmitter release, we used a mutagenesis approach. We weakened SNARE interactions of syb-2/VAMP-2 regionally by introducing destabilizing point mutations along its binding motif, targeting amino acids contributing to the hydrophobic interaction layers ([Fig. 1](#fig1){ref-type="fig"}). In most cases, we used alanine substitutions. Considering the known structure of the SNARE complex, alanines were not expected to prevent binding of synaptobrevin to syntaxin--SNAP-25 or cause clashes in the structure but would probably mildly destabilize the complex. The effects of these mutations were then tested in vitro for their effect on complex stability and assembly rate and in vivo for their effect on neurotransmitter release.

![**Overview of mutations introduced into syb-2 in the present investigation.** All targeted sites are layer residues facing the inside of the complex ([@bib26]) either at the N-terminal end (left) or at the C-terminal end (right) of the complex. In the LATA mutant, aa 32 (leucine) and aa 35 (threonine) corresponding to layers −7 and −6 were mutated to alanine. The VAVA mutant bears mutations in layers −5 and −4, where valines (residues 39 and 42) were mutated to alanines. In the C-terminal half of the complex, leucine-70 was mutated to alanine (L70A) and phenylalanine was mutated to alanine (F77A) in layers 4 and 6, respectively. In layer 8, leucine was substituted by alanine (L84A), arginine (L84N), glycine (L84G), or aspartate (L84D).](JCB_200907018_RGB_Fig1){#fig1}

Two sets of mutations were generated: the contribution of the N-terminal part of the synaptobrevin SNARE motif to triggered exocytosis was studied by use of two mutants bearing double point mutations in the most N-terminal and adjacent layers. In one mutant, syb-2 residues leucine-32 (L) and treonine-35 (T) of layers −7 and −6 were both changed to alanines, thus creating the "LATA" mutant. In layers −5 and −4, valine-39 and -42 were mutated to alanines to create the "VAVA" mutant ([Fig. 1](#fig1){ref-type="fig"}). The other set of mutations tested the contribution of the C-terminal end of the complex by introducing single point mutations into layers 4, 6, and 8, where alanines were used to replace a leucine (L70A), a phenylalanine (F77A), and a leucine (L84A), respectively.

Biophysical characterization of mutants
---------------------------------------

Assembly of a ternary complex such as the SNARE complex must involve at least two steps. Data from both in vitro ([@bib40]; [@bib25]; [@bib63]) and cellular systems ([@bib1]; [@bib65]; [@bib35]) show that the first step is SNAP-25 binding to syntaxin, forming a 1:1 acceptor complex on the plasma membrane. The second step comprises binding of synaptobrevin to this acceptor complex, thus forming the full SNARE complex. A complication of these studies is that the 1:1 syntaxin--SNAP-25 acceptor complex tends to bind to a second syntaxin in vitro, blocking the synaptobrevin-binding site ([@bib24]). To isolate the synaptobrevin-binding step, a C-terminal fragment of synaptobrevin has been used, which prevents the binding of a second syntaxin while keeping the N-terminal part of the complex accessible (the so-called ΔN complex). Full-length synaptobrevin can bind to the ΔN complex and displace the C-terminal fragment. This strategy greatly accelerates SNARE complex formation and liposome fusion in vitro ([@bib63]). These binding steps have been thoroughly dissected in vitro, using a combination of purified proteins/peptides and biophysical methods ([@bib63]; [@bib93]). It was concluded that synaptobrevin prefers to bind to the 1:1 syntaxin--SNAP-25 acceptor complex through N-terminal interaction. However, whether this conclusion can be generalized to the situation in the cell, where other factors must be responsible for keeping the 1:1 acceptor complex in the receptive conformation, remains to be established. In this study, we first characterized some of our mutations using the previously published in vitro methods ([@bib24]; [@bib93]).

As expected, alanine substitutions at either the C- or the N-terminal end of the complex did not eliminate the ability of syb-2 to create ternary SNARE complexes. Circular dichroism (CD) spectroscopy revealed that assembled complexes were only slightly destabilized as compared with wild-type (WT) complexes ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.200907018/DC1)). With the intention of testing how our mutants affect the kinetics of SNARE complex assembly in vitro, we used fluorescence anisotropy measurements and analyzed the speed of synaptobrevin binding to the ΔN complex. For these experiments, we used syntaxin-1 lacking the N-terminal H~abc~ domain. The H~abc~ domain is not part of the SNARE bundle itself, but it reduces the overall speed of assembly by inducing an intermittent shift to the closed conformation of syntaxin-1 ([@bib21]; [@bib52]). The absence of this domain is not expected to change the mechanism of assembly itself. We found that destabilization of the two most N-terminal layers (LATA mutant) of the SNARE complex reduced the speed of synaptobrevin binding to the acceptor complex, whereas no effect could be seen by mutations at the C-terminal end (L84A; [Fig. 2 A](#fig2){ref-type="fig"}). Titrating with increasing amounts of ΔN complex ([Fig. 2 B](#fig2){ref-type="fig"}), we estimated an association rate constant of 235,000 M^−1^ s^−1^ (pseudo first-order rate constant) for WT synaptobrevin, which is in reasonable agreement with recent findings ([@bib63]). This rate was decreased fivefold by the LATA mutant (44,000 M^−1^ s^−1^) but was essentially unchanged for the VAVA mutant (263,000 M^−1^ s^−1^). Thus, apparently, the integrity of layers −7 and −6 is essential for rapid binding in vitro. This was confirmed by testing the deletion mutant Δ32--35, in which 4 aa, including these two layer residues, were deleted; this mutant displayed very slow binding kinetics (\<3,000 M^−1^ s^−1^, which could not be measured accurately because of the lack of saturation; [Fig. 2 A](#fig2){ref-type="fig"}). In contrast, deleting the entire C-terminal half of the SNARE motif (Syb1--52, a deletion of 47 aa) only decreased the binding rate to 123,000 M^−1^ s^−1^ ([@bib93]). Thus, there can be little doubt (also in light of previous in vitro data \[[@bib63]\]) that the N-terminal end serves to initiate binding of synaptobrevin to the syntaxin--SNAP-25 dimer in vitro.

![**In vitro binding of syb-2 to a syntaxin--SNAP-25 acceptor complex.** (A) Fluorescence anisotropy measurements of labeled syb-2 mutants and WT protein binding to the ΔN complex. Comparison of two N-terminal mutants (LATA and VAVA) with WT syb-2 (control) and a C-terminal mutant (L84A) is shown. An N-terminally truncated syb-2 (Δ32--35, deletion of aa 32--35) displays greatly decreased binding kinetics (note the axis break on the abscissa; 100 nM synaptobrevin was added to 500 nM ΔN complex). (B) A plot of the observed binding rates of the synaptobrevin WT protein (control trace) and the LATA and VAVA mutants against the different concentrations (conc.) of the acceptor ΔN complex allows calculation of the association rate (slope of linear fits; values given in Biophysical characterization of mutants).](JCB_200907018_RGB_Fig2){#fig2}

To characterize the thermodynamical properties of the mutants used in this investigation, we made use of isothermal calorimetry (ITC; [@bib93]). We found that the LATA mutant decreased the affinity of synaptobrevin to SNARE partners from a dissociation constant (*K*~d~) of ∼2 nM ([@bib93]) to ∼44 nM, whereas the VAVA mutant had a milder but clearly distinguishable phenotype on the dissociation constant (*K*~d~ of ∼8 nM; [Table I](#tbl1){ref-type="table"}). These data confirm that both N-terminal mutations interfere with the binding of synaptobrevin to the syntaxin--SNAP-25 acceptor complex. Again, it is interesting to compare these values with previous results showing that the deletion of the entire C-terminal portion of the SNARE motif (Syb1--65, a deletion of 31 aa) only increased the *K*~d~ to 5.7 nM ([@bib93]). The N-terminal end of the synaptobrevin SNARE domain seems crucial for both binding rate and affinity of the interaction.

###### 

Thermodynamic properties of N-terminal mutations used, as determined by ITC

  Protein interaction (cell + syringe)                     *K*~d~        ΔH            −TΔS         ΔG           N
  -------------------------------------------------------- ------------- ------------- ------------ ------------ ------
                                                           *nM*          *kcal/mol*    *kcal/mol*   *kcal/mol*   
  ΔN complex + Syb1--96[a](#tblfn1){ref-type="table-fn"}   2.1 ± 0.6     −29.9 ± 0.3   18.1         −11.8        1.05
  ΔN complex + Syb F77A                                    0.8 ± 0.4     −18.8 ± 0.2   6.4          −12.4        0.99
  ΔN complex + Syb LATA                                    44.1 ± 12.3   −16.6 ± 0.4   6.5          −10.1        1.01
  ΔN complex + Syb VAVA                                    8.4 ± 2.8     −23.4 ± 0.4   12.3         −11.1        1.02

*K*~d~, dissociation constant; ΔH, binding enthalpy; T, absolute temperature in Kelvin; ΔS, entropy change; ΔG, free energy; N, stoichiometry.

These data are from [@bib93].

N-terminal destabilization
--------------------------

To test the effect of the mutations on exocytosis, we made use of adrenal chromaffin cells, which are widely used as a convenient model system ([@bib59]). By means of Ca^2+^ uncaging directly in the cell, it is possible to fuse all vesicles residing in two releasable pools, the readily releasable pool (RRP) and the slowly releasable pool (SRP; [@bib84]). Exocytosis was monitored by membrane capacitance measurements ([@bib50]) and carbon fiber amperometry ([@bib94]). Kinetic analysis was used to identify the vesicle pool sizes and their fusion kinetics. After the emptying of the pools, exocytosis persists at a sustained rate because of the priming of new vesicles for release, followed immediately by fusion as long as the Ca^2+^ concentration stays high. Thus, chromaffin cells allow the measurement of fusion kinetics, pool sizes, and priming rates in a single experiment. Because vesicular priming precedes fusion, the chromaffin cell offers a stage-specific assay in which the effect of manipulations on sequential steps of the exocytotic pathway can be accurately assessed.

We used chromaffin cells from syb-2 ([@bib70])/cellubrevin ([@bib98]) double knockout mice as a background for our study. Previous experiments showed that in chromaffin cells, cellubrevin substitutes for syb-2 in its absence, which necessitates the use of double knockout mice ([@bib8]). Whereas exocytosis in double knockout cells was abolished, viral expression of syb-2 restored both the kinetics and amplitude of secretion ([@bib8]; [@bib45]; unpublished data). Therefore, we used double knockout cells rescued with the WT syb-2 construct as the control condition in our experiments. To control for preparation differences, WT rescue was performed in parallel for each preparation included in this study. All constructs studied in these experiments (including the WT syb-2) led to \>10-fold overexpression above endogenous levels, as shown by quantitative immunostaining of expressing double knockout cells ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200907018/DC1)). Costaining against the vesicular Ca^2+^ sensor syt-1 revealed similar staining intensities for all constructs as in double knockout cells (Fig. S2), indicating that other vesicular proteins of the cells remained unaffected.

Both synaptobrevin mutants harboring mutations at the N-terminal end of the SNARE motif (LATA and VAVA mutants) showed partial rescue of secretion, but the overall amplitude of the response was reduced ([Fig. 3 Ai](#fig3){ref-type="fig"}). A more detailed view of the kinetics of release was obtained by normalization of the three traces (WT, LATA, and VAVA) to their respective amplitudes at 0.5 s after Ca^2+^ photorelease. The fact that all three traces overlapped after normalization demonstrates that the phenotype observed here is selective for the magnitude, but without effect on the kinetics of membrane fusion itself ([Fig. 3 Aii](#fig3){ref-type="fig"}). This was also shown by a kinetic analysis of capacitance traces, which was performed by fitting a sum of two exponential functions to the burst phase (0.5--1.5 s) of secretion. This analysis provided parameters describing the distinct pools (with amplitudes representing pool sizes and time constants reporting on fusion kinetics) involved in transmitter release from chromaffin cells ([Fig. 3, Bi and Bii](#fig3){ref-type="fig"}). N-terminal destabilization significantly reduced the amount of vesicles residing in the RRP and the SRP as well as the rate of the sustained component (the linear increase in the capacitance trace at times between 1.5 and 5.5 s), which reflects the speed at which vesicles undergo functional maturation. However, the kinetics (time constants) for fusion from the RRP and the SRP were not significantly affected by N-terminal destabilization, confirming that the N-terminal part of the SNARE motif is important for vesicle priming but insignificant to the actual process of triggering release (refer to [Table S1](http://www.jcb.org/cgi/content/full/jcb.200907018/DC1) for measured parameters of all mutants).

![**N-terminal mutants of syb-2 reduce pool size and sustained component when expressed in adrenal chromaffin cells.** The N-terminal mutants of syb-2 are shown in [Fig. 1](#fig1){ref-type="fig"}. (Ai) N-terminal SNARE destabilization shows a reduced secretory response in exocytosis evoked by Ca^2+^ uncaging. (top) Mean ± SEM of intracellular Ca^2+^ concentration after UV-induced Ca^2+^ uncaging at time = 0.5 s. (middle) Mean capacitance increase. (bottom) Mean amperometric current (thick traces; left ordinate) and amperometric charge (thin traces; right ordinate). All cells were from double syb-2/cellubrevin knockout mice; control cells were infected with the WT protein (WT rescue). (Aii) A detailed view of normalized traces in Ai shows that the kinetics of release are unaffected (normalized capacitance, thick traces; and normalized amperometric charge, thin traces). (Bi and Bii) Kinetic analysis reveals significant reduction of pool sizes in LATA and VAVA mutants but no effect on rate of release. Fitting of exponentials to capacitance responses was used to quantify parameters reflecting time constants (Bi) and sizes (Bii) of the RRP and SRP. The sustained component (sust.) was found as the slope of the capacitance trace between 1.5 and 5.5 s. Mean ± SEM is shown (WT rescue, *n* = 21 cells; LATA, *n* = 20 cells; and VAVA, *n* = 29 cells; and \*, P \< 0.05; \*\*, P \< 0.01; and \*\*\*, P \< 0.001 in *t* test).](JCB_200907018_RGB_Fig3){#fig3}

C-terminal assembly
-------------------

To test how assembly of the C-terminal half of the SNARE complex is involved in vesicular release, we tested several mutants. Introducing point mutations layer by layer, we progressively moved from layer 4 toward the C-terminal end of the SNARE motif, again seeking to destabilize SNARE interaction by replacing endogenous residues with alanines. A single point mutation in layer 4, in which alanine was used to replace a leucine (L70A), had a dramatic effect on exocytosis ([Fig. 4 Ai](#fig4){ref-type="fig"}): the mutant led to only marginal rescue of secretion in double knockout cells in spite of being strongly overexpressed (Fig. S2). Strikingly, overexpression of the L70A construct in WT chromaffin cells was without effect on secretion ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.200907018/DC1)), suggesting that the mutation rendered the mutant protein incapable of competing with endogenous syb-2.

![**Mutations in layers 4 and 6 severely affect transmitter release.** The mutations in layers 4 and 6 are shown in [Fig. 1](#fig1){ref-type="fig"}. (Ai and Bi) Mean secretory responses in Ca^2+^-triggered release are dramatically reduced in the L70A (Ai) and the F77A (Bi) mutant. For comparison, traces from double knockout cells (DKO) are included. Double knockout traces are pooled from an independent dataset and were not recorded in parallel to L70A and F77A measurements. Mean ± SEM of Ca^2+^ levels is shown. (Aii and Bii) Detailed view of normalized traces in Ai and Bi. (A: WT rescue, *n* = 23; L70A, *n* = 15; double knockout, *n* = 21; B: WT rescue, *n* = 8; F77A, *n* = 13; double knockout, *n* = 21.)](JCB_200907018_RGB_Fig4){#fig4}

Layer 6 of the SNARE complex is special because in this layer, a bulky phenylalanine residue (F77) from syb-2 faces the small side chains of three alanines (two from SNAP-25 and one from syntaxin-1). This phenylalanine is found in almost all R-SNARE types ([@bib46]), and thus, the extremely asymmetrical arrangement of layer 6 is conserved even in distantly related SNARE complexes such as the late endosomal complex ([@bib2]), indicating that it might be functionally important. Indeed, mutation of the phenylalanine to an alanine (F77A) almost eliminated secretion ([Fig. 4 Bi](#fig4){ref-type="fig"}). Yet, anisotropy measurements showed that the F77A mutant was able to displace the labeled C-terminal synaptobrevin fragment from the ΔN complex in vitro (Fig. S1 C). ITC measurements revealed a similar binding affinity as in the WT case ([Table I](#tbl1){ref-type="table"}), whereas the enthalpy was somewhat reduced. In conclusion, even though the region around layers 4 and 6 appears hypersensitive to mutation and essential for secretion, standard measurements in vitro do not identify problems in SNARE complex formation.

Mutating the most C-terminal layer 8 (leucine-84) to alanine ([Fig. 1](#fig1){ref-type="fig"}) resulted in a phenotype with robust rescue of secretion in response to Ca^2+^ uncaging ([Fig. 5 Ai](#fig5){ref-type="fig"}). However, detailed analysis of capacitance increase and cumulative amperometric current revealed a slowdown of the fast phase of neurotransmitter release ([Fig. 5, Aii and Aiii](#fig5){ref-type="fig"}). The specific nature of the residue used to replace the endogenous leucine was of minor importance because several different amino acids were studied, all of which showed a similar effect ([Fig. 5 Bi](#fig5){ref-type="fig"}). Even though mutants bearing an aspartate or a glycine in layer 8 also had an effect on the amplitude of the secretory response ([Fig. 5 Bi](#fig5){ref-type="fig"} and Table S1), it is striking that their effect on release kinetics was very similar and, when looking at normalized traces, even indistinguishable ([Fig. 5, Bii and Biii](#fig5){ref-type="fig"}). Thus, destabilizing SNARE interaction in layer 8 predominantly reduced the speed at which vesicles underwent fusion, suggesting that the extreme C-terminal interaction layer of the SNARE proteins is of particular importance for the very final steps of triggered exocytosis.

![**C-terminal mutants of syb-2 cause a slowdown of transmitter release.** The C-terminal mutants of syb-2 are shown in Fig. 1. (Ai and Bi) Mean secretion in flash-evoked transmitter release is slowed down. (Aii and Bii) Detailed views of normalized traces in Ai and Bi show that the kinetics of release are slowed down in all cases. (Aiii and Biii) Time constants of the RRP and SRP obtained by fitting of exponentials show slowdown of release in the L84A mutant (Aiii: control, *n* = 19; and L84A, *n* = 25) and L84N, L84G, and L84D mutations (Biii: control, *n* \> 15; L84D, *n* = 9/14; L84G, *n* = 13/17; and L84N, *n* = 15/19 for RRP/SRP time constants; and \*, P \< 0.05; \*\*, P \< 0.01; and \*\*\*, P \< 0.001 in *t* test). (Ai, Aiii, Bi, and Biii) Mean ± SEM is shown.](JCB_200907018_RGB_Fig5){#fig5}

The fusion pore is affected by C-terminal mutations
---------------------------------------------------

Exocytosis of individual vesicles can be studied by means of single spike amperometry ([@bib94]). Here, release of catecholamines can be detected by a current generated by oxidation of the transmitter at a carbon fiber electrode placed in close proximity to the cell and held at a potential of 720 mV. Typically, individual, nonoverlapping fusion events can be characterized by several parameters describing the geometrical shape of the spike ([Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.200907018/DC1)). In many spikes, initial release of transmitter from a vesicle can be observed in a so-called prespike foot, where efflux of the transmitter from the vesicle is already detected, although its diffusion is limited by the fusion pore ([@bib14]). Subsequent relaxation of the fusion pore allows for the release of the entire vesicular content, thus giving rise to the complete spike.

To elucidate to what extent weakening of SNARE interaction affects exocytosis on the level of a single vesicle, we infused expressing chromaffin cells with a solution containing 4.5 µM Ca^2+^ and characterized amperometric spikes. We strictly compared groups expressing WT protein (control) with mutants each challenging N- and C-terminal SNARE interaction. We found a selective and significant effect for C- but not N-terminal complex destabilization, exclusively reducing the prespike foot duration ([Fig. 6, A and B](#fig6){ref-type="fig"}). Properties of the actual spike, such as peak amplitude, charge, rise time, or half-width (Fig. S4, B and C) were unaltered. A reduction in foot duration implies a decreased lifetime of the fusion pore. A change in foot amplitude was not detected (Fig. S4, D and E). Note that this effect was reproducibly shown in two independent datasets, comparing control with L84A and VAVA mutants as well as comparing control with L84N and LATA mutants, respectively ([Fig. 6, A and B](#fig6){ref-type="fig"}).

![**Fusion pore stability is affected by C- but not N-terminal destabilization of the SNARE complex.** (Ai and Bi) Examples of spikes recorded by means of carbon fiber amperometry. (Aii and Bii) Mean of cumulative probability (Cum. Prob.) distributions of the prespike foot duration shows a shift to shorter feet for C-terminal synaptobrevin mutants (L84A in Aii and L84N in Bii). (Aiii and Biii) The mean foot duration (mean of cell medians) of C-terminal mutants is significantly reduced. Mean ± SEM is shown (A: WT rescue, *n* = 16 cells; VAVA, *n* = 19 cells; and L84A, *n* = 19 cells; and B: control, *n* = 14 cells; LATA, *n* = 15 cells; and L84N, *n* = 19 cells; and \*, P \< 0.05 in one-way ANOVA after log transformation yielded normally distributed homoscedastic data). (C) Proposed energy landscape for fusion (line), including barriers for vesicle priming, fusion triggering, and fusion pore expansion. The kinetic scheme comprises rate constants for pore formation (k~o~), pore closure (k~c~), and pore dilation (k~f~). In this model, the lifetime of the pore (τ~o~) is defined by the inverse sum of the rate constants k~c~ and k~f~. The dashed line shows the proposed energy landscape after C-terminal mutation in syb-2.](JCB_200907018_RGB_Fig6){#fig6}

[@bib87] suggested the use of a simplified kinetic scheme analogous to the ones used to describe ion channel gating to analyze the fusion pore duration. In that scheme, opening of a fusion pore can be followed by either reversible closure, producing a stand-alone foot (SAF), or irreversible pore expansion, leading to full collapse ([Fig. 6 C](#fig6){ref-type="fig"}; [@bib88]). Within this framework, a decreased lifetime of the fusion pore (τ~o~) could be caused by an increased rate of expansion (k~f~), an increased rate of reclosure (k~c~), or both. These possibilities, in theory, can be distinguished by analyzing the fraction of SAFs, which should increase in the first case and decrease in the second case. Using two different criteria for the identification of SAFs, one based on a more rectangular shape expected for these events and one based on their lower amplitude, we did not detect any changes in the fraction of SAFs upon C-terminal mutation ([Fig. S5](http://www.jcb.org/cgi/content/full/jcb.200907018/DC1)). This indicates that either most events detected were not SAFs or that the changes seen were not caused by modification of a single transition rate in an otherwise unchanged kinetic scheme.

In conclusion, C-terminal mutation slowed triggered exocytosis and decreased the lifetime of the fusion pore. These findings are consistent with a hypothesized energy landscape of the fusion reaction, in which C-terminal destabilization has two effects: to increase the fusion barrier and to destabilize the fusion pore intermediate ([Fig. 6 C](#fig6){ref-type="fig"}).

Discussion
==========

The data presented in this study allow inferences about the events leading up to exocytosis of secretory vesicles. Destabilizing the SNARE bundle by N-terminal alanine substitution in syb-2 led to smaller primed vesicle pools and a shallower sustained phase, indicating that the forward priming rate under elevated Ca^2+^ conditions is reduced. This occurred in the absence of any detectable change in the triggering rate or fusion pore properties. The physiological changes correlated with a decreased association rate and affinity for the acceptor complex, as measured in vitro using biophysical methods, especially when the two N-terminal layers (−7 and −6) were mutated (LATA). The VAVA mutation (located in layers −5 and −4) resulted in milder consequences in the in vitro situation, although the affinity for the ΔN complex was reduced. In physiological measurements, both mutations had indistinguishable effects. The most likely reason for this discrepancy is that in vivo, additional catalyzing factors, possibly Munc18 ([@bib20]) and/or CAPS (Ca^2+^-dependent activator protein for secretion; [@bib44]), cause synaptobrevin to associate with syntaxin--SNAP-25 in a slightly different sequence or over a longer stretch than in vitro. This interpretation was supported by biochemical experiments aimed at testing the effect of layers −5 and −4 (where the VAVA mutation is localized) in the absence of layers −6 and −7 (harboring the LATA mutation). This experiment (Fig. S1 B) showed a further reduction of association rate by the VAVA mutation compared with mutants merely bearing a deletion of layers −7 and −6 (Δ32--35VAVA and Δ32--35 in Fig. S1 B). Overall, our data indicate that assembly of the N-terminal end of the ternary SNARE complex happens during vesicle priming, without being directly linked to downstream events involved in triggering release. The experiments presented in this study were necessary to draw this conclusion because previous mutations introduced in SNAP-25 ([@bib76]) might have affected upstream processes, including the formation of the syntaxin--SNAP-25 acceptor complex involved in docking ([@bib19]). Only synaptobrevin mutations can clearly dissect the involvement of the ternary SNARE complex in exocytosis. The current data make a very strong case for the sequential two-step N- to C-terminal assembly of the ternary SNARE complex. In contrast, our data are hard to reconcile with models in which the C-terminal end of synaptobrevin joins the complex first ([@bib47]).

As was the case for SNAP-25 ([@bib96]; [@bib90]; [@bib76]), mutation in the C-most interaction layer, layer 8 in synaptobrevin, caused a slowdown of exocytosis triggering. This phenotype is relatively rare, demonstrating the robustness of the exocytosis machinery ([@bib60]). The slowdown upon mutation indicates that assembly of this layer is coupled to Ca^2+^ binding to the Ca^2+^ sensor synaptotagmin, which times release with respect to the Ca^2+^ signal ([@bib53]; for reviews see [@bib11]; [@bib66]; [@bib79]). The effect seems exclusive to the two to three most C-terminal interaction layers. It is of interest to note that both in vitro and in vivo studies have identified the last couple of C-terminal layers as more essential for release than the linker, which connects the SNARE complex to the transmembrane anchor of synaptobrevin ([@bib55]; [@bib56]; [@bib45]; [@bib73]). Insertions in the linker of several amino acids only led to minor changes in release in chromaffin cells ([@bib45]), whereas we show in this study that even rather conservative mutations in the last three SNARE layers suffice to abolish release. Thus, whereas C-terminal assembly is clearly essential for exocytosis, the exact structure of the linker region, which, according to current understanding, couples the released energy to the membrane, is less crucial.

Mutation of the C-most layer of synaptobrevin caused a reduction in duration of the prespike foot, reflecting a shorter lifetime of the fusion pore. Our analysis of small events, which might represent SAFs, did not reveal changes that would be consistent with an increased rate of fusion pore reclosure. Thus, it seems that the mutation has changed the energy landscape for fusion pore formation and dilation in a more complex way, such that the barrier for fusion triggering is higher (leading to slower time constants of fusion), whereas the barrier for fusion pore expansion is smaller (leading to a fusion pore with shorter life time; [Fig. 6 C](#fig6){ref-type="fig"}). The finding that mutations in the C-most interaction layer modified prespike feet implies that C-terminal SNARE complex assembly is involved in generating the fusion pore ([@bib16]; [@bib30]; [@bib23]). However, whereas a previous publication reported an increased foot duration upon C-terminal mutation of SNAP-25 ([@bib23]), we found in this study that the foot duration was decreased. This might be caused by the difference in protocol because in the previous study, using overexpression in bovine cells, vesicles might fuse using a mixture of WT (endogenous) and mutated protein. Another possibility is that there is a different role of syb-2 and SNAP-25 in fusion pore formation. This idea is supported by the finding of opposite effects (decrease and increase, respectively) on fusion pore duration after knockout of SNAP-25 ([@bib75]) and syb-2 ([@bib8]).

Our finding that more N-terminal mutants did not modify fusion pore duration seems to partially disagree with an overexpression study in PC12 cells ([@bib37]). We cannot rule out the possibility that N-terminal mutations increase fusion pore duration in a way not detectable by our measurements because our use of cell-averaged statistics, which was necessary because of significant cell to cell variability ([@bib15]), results in less power than when spikes are combined across cells ([@bib37]). In addition, differences in cell type or stimulation protocol might explain the differences. Of note is the fact that our mutation of layer 8 led to slower triggering rates and shorter fusion pore durations, features which have both been associated with a lack of syt-1--SNARE interaction ([@bib4]; [@bib85]). Thus, the finding might be explained by postulating that C-terminal mutation decouples exocytosis from syt-1 action ([@bib99]).

Our mutations in layers 4 and 6 add to previous evidence that the transition zone between the N-terminal three quarters and the C-terminal one quarter of the SNARE bundle is a critical area, as even relatively conservative mutations here are not tolerated ([@bib61]; [@bib67]; [@bib76]). Because this area separates the priming from the triggering reaction, it might constitute a switch region, allowing rapid assembly of the C-terminal end. Notably, the L70A mutation in synaptobrevin that we studied here was not dominant when overexpressed in WT cells, whereas the previously isolated double alanine mutation in layer 5 of SNAP-25 eliminated release even in WT cells ([@bib76]). With such data, the question of whether the protein is correctly localized becomes imminent. Immunolocalization indicated that the mutated protein is present in spots in the cytoplasm (Fig. S2), which probably corresponds to vesicles; however, the expression system (Semliki Forest virus) causes massive overexpression and results in large amounts of proteins in other locations of the cell. Even though this apparently does not compromise rescue of double knockout cells, it cannot be ruled out that mislocalized protein could interfere with function in the case of the L70A mutant. However, if taken at face value, our data on the L70A mutant could indicate that after assembly of the N-terminal end of the SNARE bundle, synaptobrevin can dissociate again if the switch associated with the C-terminal end of the complex is not functional. Indeed, assembly of the N-terminal part of synaptobrevin to syntaxin--SNAP-25 seems to be a reversible process until the C-terminal end joins ([@bib93]). This might also explain the data obtained in this study ([Fig. 5 B](#fig5){ref-type="fig"}) and elsewhere ([@bib45]) that show that more severe C-terminal mutations tend to interfere with upstream steps in vesicle priming. The mechanism that prevents dissociation of syb-2 in the normal case might consist of complexin or syt-1 binding to the partly assembled SNARE complex, thereby stabilizing it while keeping the C-terminal end of synaptobrevin in a ready to go configuration. Failure of synaptotagmin binding would leave mutated synaptobrevin only loosely associated, eventually leading to its replacement by WT protein. The idea that synaptotagmin or complexin might bind to and stabilize the SNARE complex in a cocked configuration is consistent with the observation that the abundance of both complexin and synaptotagmin modify the size of the primed vesicle pools in chromaffin cells ([@bib57]; [@bib10]).

Recent data obtained with a surface force apparatus indicated that assembly of the SNARE complex is associated with a binding energy of ∼35 k~B~T ([@bib49]), whereas ITC measurements gave a value close to 20 k~B~T ([@bib93]). Both studies conclude that (a) assembly of the N-terminal three quarters of the SNARE bundle releases considerable energy and (b) assembly of the C-terminal one quarter releases much less energy, even though the latter conclusion could have been affected by the absence of a transmembrane domain in both studies. Together with our data, and for topological reasons, we would argue that the main part of the energy of formation of the complex goes into initiation and stabilization of the primed or cocked vesicle state but not into the triggering reaction itself. However, the primed vesicle has probably already overcome part of the energy barrier for fusion. The final triggering of release then coincides with the assembly of the C-terminal end of the complex. Even though this end might liberate less energy, the slowdown seen upon mutation argues for its contribution to the process. The main open question is how C-terminal SNARE complex "zippering" is prevented from occurring prematurely. Recent data indicate that complexin is involved in this process ([@bib31], [@bib32]; [@bib68]; [@bib42]; [@bib54]), possibly by forming an alternative complex with the C-terminal end of the SNARE complex ([@bib97]; [@bib32]). However, because complexin mainly binds to synaptobrevin in the ternary SNARE complex ([@bib12]) and therefore can only interact with the complex after it starts to assemble, it remains unclear how it can succeed in arresting fusion. We suggest that the transition zone around layers 4--6, possibly together with structural features recently identified in the SNAP-25 linker ([@bib58]), and the C-terminal weakness of the complex constitute endogenous properties, which prevent spontaneous assembly of the SNARE complex. These features allow time for complexin and/or synaptotagmin (for review see [@bib79]) to interact and freeze the SNARE complex in a ready to go configuration.

Materials and methods
=====================

Protein constructs and purification
-----------------------------------

All recombinant proteins (syntaxin-1a, SNAP-25A, and syb-2) were derived from cDNAs from rat (*Rattus norvegicus*). All expression constructs were in the pET28a expression vector. As basic expression construct for the neuronal SNARE, we used the SNARE (H3) domain of syntaxin-1a (aa 180--262), the soluble portion of synaptobrevin (aa 1--96; Syb1--96), and a cysteine-free variant of SNAP-25A (aa 1--206; [@bib28]; [@bib24]; [@bib63]). In addition, various synaptobrevin mutants and truncations were used, and single cysteines were introduced at position 28 for labeling purposes: Syb1--96 L32A, T35A, S28C; Syb1--96 V39A, V42A, S28C; Syb1--96 L84A, S28C; Syb1--96 L84N, S28C; Syb1--96 Δ32--35, S28C; and Syb1--96 Δ32--35, V39A, V42A, S28C. They were cloned into the pET28a vector (EMD) via Nde1 and Xho1 sites, resulting, after cleavage of the His6-tag by thrombin, in the additional N-terminal sequence GSHM. All proteins were expressed in *Escherichia coli* strain BL21 (DE3) and purified by Ni^2+^--nitrilotriacetic acid chromatography followed by ion exchange chromatography on an Äkta system (GE Healthcare; [@bib27]). His6 tags were generally removed using thrombin. All SNARE complexes were purified using a Mono-Q column (GE Healthcare) after overnight assembly of the purified monomers. The following ternary complexes were used: Syb49--96:SyxH3:SNAP-25 (ΔN complex) and Syb1--96 C28 mutants:SyxH3:SNAP-25. Protein concentrations were determined by absorption at 280 nm in 6 M GdnHCl and/or using the Bradford assay.

ITC
---

ITC was performed on a VP-ITC instrument (MicroCal) at 25°C. Samples were dialyzed twice against degassed phosphate buffer (20 mM Na phosphate, pH 7.4, 150 mM NaCl, and 1 mM DTT). Typically, an initial 5-µl injection was followed by several 15-µl injections. The heat change per injection was integrated to yield the molar enthalpy for each injection. Blank titrations, which were performed by injecting ligand into buffer, were subtracted from each dataset. All ITC experiments were performed at least twice. The resulting binding isotherms were analyzed using the Origin ITC software packet (MicroCal) to obtain the binding enthalpy (ΔH), the stoichiometry (N), and the association constant (K~A~). We used a one-site binding model that assumes that one or more ligands can bind independently. The dissociation constant (*K*~d~) and the binding free energy (ΔG) were calculated using the basic thermodynamic relationships *K*~d~ = K~A~^−1^, ΔG = −RT lnK~A~, and ΔG = ΔH − TΔS.

Fluorescence spectroscopy
-------------------------

All measurements were performed in a Fluorolog 3 spectrometer in T configuration equipped for polarization (model FL322; HORIBA Jobin Yvon). In binding experiments, single cysteine variants of syb-2 were labeled with Alexa Fluor 488 C5 maleimide (Invitrogen) according to the manufacturer's instructions and added to the ΔN complex. All experiments were performed at 25°C in 1-cm quartz cuvettes (Hellma) in phosphate buffer (20 mM Na phosphate, pH 7.4, 150 mM NaCl, and 1 mM DTT) using quartz cuvettes with a path length of 10 × 4 mm (Hellma) equipped with a magnetic stirrer. Fluorescence anisotropy was measured. The anisotropy reports on the local flexibility of the labeled residue, which increases upon complex formation and decreases upon dissociation ([@bib24]; [@bib63]). In displacement experiments, the syb-2 fragment (Syb49--96) was labeled, and the decrease in anisotropy after its displacement by WT or mutated synaptobrevin was measured. The G factor was calculated according to G = I~HV~/I~HH~, where I is the fluorescence intensity, the first subscript letter indicates the direction of the exciting light, and the second subscript letter indicates the direction of emitted light. The intensities of the vertically (V) and horizontally (H) polarized emission light after excitation by vertically polarized light were measured. The anisotropy (r) was determined according to r = (I~VV~ − G I~VH~)/(I~VV~ + 2 G I~VH~).

CD spectroscopy
---------------

CD measurements were performed using a Chirascan instrument (Applied Photophysics; [@bib28]). Hellma quartz cuvettes with a path length of 0.1 cm were used. The measurements were performed at 25°C. For thermal denaturation experiments, the purified complexes were dialyzed against phosphate buffer. The ellipticity at 222 nm was recorded between 25 and 95°C at a temperature increment of 30°C/h.

Adrenal chromaffin cell culture and expression of mutants
---------------------------------------------------------

The mouse strain was kept heterozygous for syb-2 and homozygous null for cellubrevin, and double knockouts were created by crossing heterozygous and recovered by Cesarean section on embryonic day 18. Embryonic adrenal glands were dissected out, placed in filtered Locke's solution (154 mM NaCl, 5.6 mM KCl, 0.85 mM NaH~2~PO~4~, 2.15 mM Na~2~HPO~4~, and 10 mM glucose, pH 7.0), and cleaned free of connective tissue. The glands were incubated with 0.2 ml of papain solution (see below) at 37°C for 40 min with slow shaking, followed by the addition of 150 µl of inactivating solution for 5 min. The solution was then carefully replaced by 0.2 ml enriched DME, and the glands were triturated gently through a 200-µl pipette tip. 50 µl of the cell suspension was plated on each sterile coverslip in 6-well plates, and the cells were allowed to settle before supplementing with enriched medium. The cells were incubated at 37°C and 8% CO~2~ and used within 3 d. Papain solution: 250 ml DME (Linaris) supplemented with 50 mg [l]{.smallcaps}-cysteine, 2.5 ml of 0.1 M CaCl~2~, 2.5 ml of 50 mM EDTA, and 20--25 U/ml papain (Worthington Biochemical) and equilibrated with 5% CO~2~. Inactivating solution: 225 ml DME supplemented with 25 ml of heat-inactivated fetal calf serum (Invitrogen), 625 mg albumin, and 625 mg trypsin inhibitor (Sigma-Aldrich). Enriched DME: 500 ml DME supplemented with 2 ml penicillin/streptomycin (Invitrogen) and 5 ml insulin-transferrin-selenium-X (Invitrogen).

Viral constructs containing a mouse syb-2 ORF followed by an internal ribosome entry site and EGFP were made in the pSFV1 plasmid, and Semliki Forest viruses were generated and used for the transfection of chromaffin cells as previously described ([@bib3]). Mutations were introduced into the pSFV1-based plasmid by PCR mutagenesis, and all constructs were verified by sequencing. After the addition of viruses to the cells, 4 h were allowed for expression of the protein. Control and mutant constructs were expressed in cells from the same preparations of syb-2/cellubrevin double knockout mice to cancel variability between preparations.

Exocytosis measurements
-----------------------

Conventional whole cell patch-clamp recordings were performed at room temperature with Sylgard-coated 3--5-MΩ pipettes (Kimax-51; Kimble Chase). An EPC-9 patch-clamp amplifier was used together with the Pulse software package (HEKA). Capacitance measurements were performed by using the Lindau-Neher technique implemented as the "sine + dc" mode of the software lock-in extension of Pulse, which allows long-duration capacitance measurements in a single sweep. A 1,000-Hz, 70-mV peak to peak sinusoid voltage stimulus was superimposed onto a DC holding potential of −70 mV. Currents were filtered at 3 kHz and sampled at 12 kHz.

The external solution contained 145 mM NaCl, 2.8 mM KCl, 2 mM CaCl~2~, 1 mM MgCl~2~, and 10 mM Hepes plus 2 mg/ml [d]{.smallcaps}-glucose, pH 7.2 (osmolarity was adjusted to 310 mOsM). The pipette solution contained 100 mM Cs-glutamate, 8 mM NaCl, 4 mM CaCl~2~, 32 mM Hepes, 2 mM Mg-ATP, 0.3 mM GTP, 1 mM ascorbic acid, 5 mM nitrophenyl-EGTA (Invitrogen), 0.4 mM fura-4F (Invitrogen), and 0.4 mM furaptra (Invitrogen), pH 7.2 (osmolarity was adjusted to 300 mOsM). Compared with previous experiments ([@bib83]; [@bib76]), the intracellular solution was modified by the addition of ascorbic acid, which protects against photodamage of the fura dyes upon uncaging with UV light. This allows a simplification of the Ca^2+^ calibration because postflash calibration ([@bib41]) becomes unnecessary.

Flashes of UV light were generated by a flash lamp (Rapp Optoelektronik), and fluorescence excitation light was generated by a monochromator (TILL Photonics); these were coupled into the epifluorescence port of an inverted microscope (Axiovert 100; Carl Zeiss, Inc.) with a 40× Fluar objective (Carl Zeiss, Inc.). The fluorescent dyes were excited at 350/380 nm, and the illumination area was reduced to cover only the diameter of the cell. Emitted light was detected with a photomultiplier, filtered at 3 kHz, and sampled at 12 kHz by Pulse software. The fluorescence ratio signal was calibrated in separate experiments by infusing the cell with solutions with known \[Ca^2+^\]~i~ buffered by 20 mM BAPTA (Invitrogen) or 1,3-Diamino-2-hydroxy-propane-N,N,N',N'-tetraacetic acid (DPTA; Sigma-Aldrich). The \[Ca^2+^\]~i~ was calculated using a *K*~d~ of 0.222 µM for BAPTA and 80 µM for DPTA while taking into account Ca^2+^ binding to the dyes, nitrophenyl-EGTA and ATP, using a custom-written macro running in IgorPro (WaveMetrics). Fluorescent excitation light was used not only to measure \[Ca^2+^\]~i~ but also to adjust \[Ca^2+^\]~i~ by inducing gradual photolysis of the Ca^2+^ cage before the flash, such that cells could be studied under conditions of uniform preflash \[Ca^2+^\]~i~ ([@bib83]).

Capacitance, Ca^2+^, and amperometric traces were imported to IgorPro for analysis. The displayed Ca^2+^ concentrations, capacitance traces, and amperometric currents were averaged over all cells recorded for each condition. Pool sizes and fusion time constants were obtained by fitting a sum of exponential functions to individual capacitance traces ([@bib75]). The function fitted contained two exponential components for the exocytotic burst component, which have previously been associated with two different vesicles pools: the RRP and the SRP, respectively ([@bib84]; [@bib83]). The sizes of these pools were taken from the amplitude of the corresponding exponential component, and the time constant was reported as a measure of fusion speed. The exocytotic burst (fusion of RRP and SRP) took place within the first second after a step increase in the Ca^2+^ concentration. The near-linear sustained component, which followed, was calculated by taking the value of the capacitance trace 5 s after photorelease of Ca^2+^ and subtracting the value after 1 s. The result was given as capacitance increase per second.

Data are represented as mean ± SEM, with *n* denoting the number of cells. Statistical analysis was performed using *t* tests on homoscedastic data and assessed by Levene's test of equality of variance. Where necessary, heteroscedastic data were log-transformed to yield homoscedastic data before testing.

Data for amperometric spike analysis were obtained in two independent experimental datasets, each comparing an N- and C-terminal mutant with WT protein in cells from double knockout mice. Carbon fibers were 5 µm in diameter (BP Amoco Chemical Co.), insulated by electropaint deposition ([@bib72]), frequently cut between recordings, and systematically switched between all conditions tested. The fibers were gently pressed against the cell during recording. Fibers were clamped to 720 mV, and currents were filtered at 3 kHz by an EPC-7 (HEKA). Currents were acquired at 12 kHz and filtered off-line using a Gaussian filter with a cut-off set at 1 kHz. Filtering, spike detection, and analysis were performed using a custom-written macro running under IgorPro. Statistics were performed using the mean of cell medians of each parameter because amperometric parameters generally display very large cell to cell variability. Significance levels were assayed by analysis of variance (ANOVA). The effect of recording sequence, animal preparations, and different fibers were tested by ANOVA but were all nonsignificant factors.

Immunostaining and imaging
--------------------------

Chromaffin cells were cultured on poly-[l]{.smallcaps}-lysine--coated coverslips, fixed in 3.7% PFA in PBS for 20 min, washed, and permeabilized in 0.2% Triton X-100. Remaining PFA was neutralized in 50 mM NH~4~Cl. Cells were blocked in 2% bovine albumin serum (Sigma-Aldrich) and incubated with primary antibodies (1:500 mouse anti--syb-2 and 1:200 rabbit anti--syt-1; both provided by R. Jahn, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany) for 2 h. Cells were washed four times, incubated with secondary antibodies (1:200 Alexa Fluor 546--conjugated goat anti--mouse and 1:200 Alexa Fluor 647--conjugated goat anti--rabbit), washed, and mounted for imaging. Fluorescence quantification was performed in PBS at room temperature on a microscope (Axiovert 200; Carl Zeiss, Inc.) equipped with a 63× NA 1.2 C-Apochromat water-immersion objective. Fluorescence excitation was achieved by monochromatic light (Polychrome V; TILL Photonics). Images were acquired by a camera (Sensicam; PCO Imaging) and analyzed using TILLvisION (version 4.0.1; TILL Photonics). Fluorescence levels were quantified as the integrated intensity of a square region of the image containing the cell minus the intensity of a background region of the same size. Data were averaged over cells and are represented as mean and SEM. Confocal imaging was performed in PBS at room temperature on a microscope (TCS SP5; Leica) with an HCX Plan-Apochromat lambda blue 63× NA 1.4 oil UV objective. Image processing was used using LAS AF software (version 1.7.0 build 1111; Leica).

Online supplemental material
----------------------------

Fig. S1 shows that synaptobrevin mutants form stable complexes and that fast assembly requires interaction of the first four N-terminal layers. Fig. S2 shows localization and expression levels of all mutants tested by quantitative immunostaining. Fig. S3 shows that overexpression of the L70A mutant in WT (control) chromaffin cells does not change secretion. Fig. S4 shows cumulative probability plots for all measured single spike parameters for the dataset displayed in [Fig. 6](#fig6){ref-type="fig"} in addition to foot amplitudes as a function of imposing a duration threshold. Fig. S5 is an attempt to detect SAFs in embryonic mouse chromaffin cells using two different criteria. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200907018/DC1>.
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